Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

140 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Advances in antiretroviral therapy.
Sobieszczyk ME, Jones J, Wilkin T, Hammer SM. Sobieszczyk ME, et al. Top HIV Med. 2006 Mar-Apr;14(1):36-62. Top HIV Med. 2006. PMID: 16641526
Advances in antiretroviral therapy.
Sobieszczyk ME, Talley AK, Wilkin T, Hammer SM. Sobieszczyk ME, et al. Top HIV Med. 2005 Mar-Apr;13(1):24-44. Top HIV Med. 2005. PMID: 15849370
The challenge of HIV-1 subtype diversity.
Taylor BS, Sobieszczyk ME, McCutchan FE, Hammer SM. Taylor BS, et al. Among authors: sobieszczyk me. N Engl J Med. 2008 Apr 10;358(15):1590-602. doi: 10.1056/NEJMra0706737. N Engl J Med. 2008. PMID: 18403767 Free PMC article. Review. No abstract available.
Extended follow-up confirms early vaccine-enhanced risk of HIV acquisition and demonstrates waning effect over time among participants in a randomized trial of recombinant adenovirus HIV vaccine (Step Study).
Duerr A, Huang Y, Buchbinder S, Coombs RW, Sanchez J, del Rio C, Casapia M, Santiago S, Gilbert P, Corey L, Robertson MN; Step/HVTN 504 Study Team. Duerr A, et al. J Infect Dis. 2012 Jul 15;206(2):258-66. doi: 10.1093/infdis/jis342. Epub 2012 May 4. J Infect Dis. 2012. PMID: 22561365 Free PMC article. Clinical Trial.
Intentions to use preexposure prophylaxis among current phase 2B preventive HIV-1 vaccine efficacy trial participants.
Fuchs JD, Sobieszczyk ME, Madenwald T, Grove D, Karuna ST, Andrasik M, Sherwat A, Broder G, Mayer K, Koblin B, Hammer S; HVTN 505 Protocol Team. Fuchs JD, et al. Among authors: sobieszczyk me. J Acquir Immune Defic Syndr. 2013 Jul 1;63(3):259-62. doi: 10.1097/QAI.0b013e318296df94. J Acquir Immune Defic Syndr. 2013. PMID: 23614998 Free PMC article. Clinical Trial.
140 results